| Bioactivity | UM-3006 is a highly efficient TLR7/8 agonist that enhances immune responses by activating the TLR signaling pathway. UM-3006 holds significant research and application potential in the fields of vaccine adjuvants and immune diseases[1]. |
| CAS | 1927013-87-3 |
| Formula | C20H34N6O2 |
| Molar Mass | 390.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Massena CJ, et al. A tractable covalent linker strategy for the production of immunogenic antigen-TLR7/8L bioconjugates. Chem Commun (Camb). 2021 May 11;57(38):4698-4701. |